Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Acharya, G., & Park, K. (2006). Mechanisms of controlled drug release from drug-eluting stents. Adv. Drug Deliv. Rev., 58, 387–401.
Alpert, S. (1995). Required biocompatibility training and toxicology profiles for evaluation of medical devices. CDRH, U.S. Food and Drug Administration.
Baldi, A., Gu, Y., Loftness, P., Siegel, R. A., & Ziaie, B. (2003). A hydrogel-actuated environmentally-sensitive microvalve for active flow control. J. Microelectromechanical Syst., 12, 613–621.
Cho, Y. W., Lee, J., Lee, S. C., Huh, K. M., & Park, K. (2004). Hydrotropic agents for study of in vitro paclitaxel release from polymeric micelles. J. Control. Release, 97, 249–57.
Chu, L. Y., Liang, Y. J., Chen, W. M., Ju, X. J., & Wang, H. D. (2004). Preparation of glucose-sensitive microcapsules with a porous membrane and functional gates. Colloids Surf. B: Biointerfaces, 37, 9–14.
Chytil, P., Etrych, T., Konak, C., Sirova, M., Mrkvan, T., Rihova, B., & Ulbrich, K. (2006). Properties of HPMA copolymer-doxorubicin conjugates with pH-controlled activation: effect of polymer chain modification. J. Control. Release, 115, 26–36.
Corot, C., Robert, P., Idee, J. M., & Port, M. (2006). Recent advances in iron oxide nanocrystal technology for medical imaging. Adv. Drug Deliv. Rev., 58, 1471–504.
Craighead, H. (2006). Future lab-on-a-chip technologies for interrogating individual molecules. Nature, 442, 387–93.
Davis, F. F. (2002). The origin of pegnology. Adv. Drug Deliv. Rev., 54, 457–8.
De Geest, B. G., Dejugnat, C., Verhoeven, E., Sukhorukov, G. B., Jonas, A. M., Plain, J., Demeester, J., & De Smedt, S. C. (2006). Layer-by-layer coating of degradable microgels for pulsed drug delivery. J. Control. Release, 116, 159–69.
Demello, A. J. (2006). Control and detection of chemical reactions in microfluidic systems. Nature, 442, 394–402.
Duncan, R. (2006). Polymer conjugates as anticancer nanomedicines. Nat. Rev. Cancer, 6, 688–701.
Duncan, R., Lloyd, J. B., & Kopecek, J. (1980). Degradation of side chains of N-(2-hydroxypropyl) methacrylamide copolymers by lysosomal enzymes. Biochem. Biophys. Res. Commun., 94, 284–90.
Duncan, R., Vicent, M. J., Greco, F., & Nicholson, R. I. (2005). Polymer-drug conjugates: towards a novel approach for the treatment of endocrine-related cancer. Endocr. Relat. Cancer, 12 Suppl 1, S189–99.
El-Ali, J., Sorger, P. K., & Jensen, K. F. (2006). Cells on chips. Nature, 442, 403–11.
FDA. (Mar 2005). “Challenge and Opportunity on the Critical Path to New Medical Products.”
Franks, A. (1987). Nanotechnology. J. Phys. E: Sci. Instrum., 20, 1442–1451.
Freitas, S., Merkle, H. P., & Gander, B. (2005). Microencapsulation by solvent extraction/evaporation: reviewing the state of the art of microsphere preparation process technology. J. Control. Release, 102, 313–32.
Gao, S. Q., Lu, Z. R., Petri, B., Kopeckova, P., & Kopecek, J. (2006). Colon-specific 9-aminocamptothecin-HPMA copolymer conjugates containing a 1,6-elimination spacer. J. Control. Release, 110, 323–31.
Goldstein, D., Nassar, T., Lambert, G., Kadouche, J., & Benita, S. (2005). The design and evaluation of a novel targeted drug delivery system using cationic emulsion-antibody conjugates. J. Control. Release, 108, 418–32.
Greco, F., Vicent, M. J., Gee, S., Jones, A. T., Gee, J., Nicholson, R. I., & Duncan, R. (2007). Investigating the mechanism of enhanced cytotoxicity of HPMA copolymer-Dox-AGM in breast cancer cells. J. Control. Release, 117, 28–39.
Hirsch, L. R., Gobin, A. M., Lowery, A. R., Tam, F., Drezek, R. A., Halas, N. J., & West, J. L. (2006). Metal nanoshells. Ann. Biomed. Eng., 34, 15–22.
Ho, D. H., Brown, N. S., Yen, A., Holmes, R., Keating, M., Abuchowski, A., Newman, R. A., & Krakoff, I. H. (1986). Clinical pharmacology of polyethylene glycol-L-asparaginase. Drug Metab. Dispos., 14, 349–52.
Ho, Y. P., Chen, H. H., Leong, K. W., & Wang, T. H. (2006). Evaluating the intracellular stability and unpacking of DNA nanocomplexes by quantum dots-FRET. J. Control. Release, 116, 83–9.
Hruby, M., Konak, C., & Ulbrich, K. (2005). Polymeric micellar pH-sensitive drug delivery system for doxorubicin. J. Control. Release, 103, 137–48.
Huang, L. Y., & Yang, M. C. (2006). Hemocompatibility of layer-by-layer hyaluronic acid/heparin nanostructure coating on stainless steel for cardiovascular stents and its use for drug delivery. J. Nanosci. Nanotechnol., 6, 3163–70.
Huh, K. M., Lee, S. C., Cho, Y. W., Lee, J., Jeong, J. H., & Park, K. (2005). Hydrotropic polymer micelle system for delivery of paclitaxel. J. Control. Release, 101, 59–68.
International Risk Governance Council, Switzerland. (2006, April). “Survey on nanotechnology governance.” Survey on nanotechnology governance.
International Organization for Standardization, Switzerland. (2007). “Biological evaluation of medical devices.” ISO 10993 Standard Series.
Janasek, D., Franzke, J., & Manz, A. (2006). Scaling and the design of miniaturized chemical-analysis systems. Nature, 442, 374–80.
Jotterand, F. (2006). The politicization of science and technology: its implications for nanotechnology. J. Law Med. Ethics, 34, 658–66.
Kim, J. J., & Park, K. (2001). Modulated insulin delivery from glucose-sensitive hydrogel dosage forms. J. Control. Release, 77, 39–47.
Kwon, I. K., Jeong, S. H., Kang, E., & Park, K. (2006). Chapter 13: Nanoparticulate drug delivery systems for cancer therapy. New York, American Scientific Publishers.
Lanza, G. M., Yu, X., Winter, P. M., Abendschein, D. R., Karukstis, K. K., Scott, M. J., Chinen, L. K., Fuhrhop, R. W., Scherrer, D. E., & Wickline, S. A. (2002). Targeted antiproliferative drug delivery to vascular smooth muscle cells with a magnetic resonance imaging nanoparticle contrast agent: implications for rational therapy of restenosis. Circulation, 106, 2842–7.
Lee, E. S., Na, K., & Bae, Y. H. (2005a). Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor. J. Control. Release, 103, 405–18.
Lee, E. S., Na, K., & Bae, Y. H. (2005b). Super pH-sensitive multifunctional polymeric micelle. Nano. Lett., 5, 325–9.
Lee, E. S., Shin, H. J., Na, K., & Bae, Y. H. (2003). Poly(L-histidine)-PEG block copolymer micelles and pH-induced destabilization. J. Control. Release, 90, 363–74.
Lee, J., Lee, S. C., Acharya, G., Chang, C. J., & Park, K. (2003). Hydrotropic solubilization of paclitaxel: analysis of chemical structures for hydrotropic property. Pharm. Res., 20, 1022–30.
Lee, S., Youn, Y. S., Lee, S. H., Byun, Y., & Lee, K. C. (2006). PEGylated glucagon-like peptide-1 displays preserved effects on insulin release in isolated pancreatic islets and improved biological activity in db/db mice. Diabetologia, 49, 1608–11.
Levin, A. D., Jonas, M., Hwang, C. W., & Edelman, E. R. (2005). Local and systemic drug competition in drug-eluting stent tissue deposition properties. J. Control. Release, 109, 236–43.
Li, Y., Ho Duc, H. L., Tyler, B., Williams, T., Tupper, M., Langer, R., Brem, H., & Cima, M. J. (2005). In vivo delivery of BCNU from a MEMS device to a tumor model. J. Control. Release, 106, 138–45.
Li, Y., Shawgo, R. S., Tyler, B., Henderson, P. T., Vogel, J. S., Rosenberg, A., Storm, P. B., Langer, R., Brem, H., & Cima, M. J. (2004). In vivo release from a drug delivery MEMS device. J. Control. Release, 100, 211–9.
Lu, W., Zhang, Y., Tan, Y. Z., Hu, K. L., Jiang, X. G., & Fu, S. K. (2005). Cationic albumin-conjugated pegylated nanoparticles as novel drug carrier for brain delivery. J. Control. Release, 107, 428–48.
Lukyanov, A. N., Elbayoumi, T. A., Chakilam, A. R., & Torchilin, V. P. (2004). Tumor-targeted liposomes: doxorubicin-loaded long-circulating liposomes modified with anti-cancer antibody. J. Control. Release, 100, 135–44.
Maloney, J. M., Uhland, S. A., Polito, B. F., Sheppard, N. F., Jr., Pelta, C. M., & Santini, J. T., Jr. (2005). Electrothermally activated microchips for implantable drug delivery and biosensing. J. Control. Release, 109, 244–55.
Michalet, X., Pinaud, F. F., Bentolila, L. A., Tsay, J. M., Doose, S., Li, J. J., Sundaresan, G., Wu, A. M., Gambhir, S. S., & Weiss, S. (2005). Quantum dots for live cells, in vivo imaging, and diagnostics. Science, 307, 538–44.
Miyata, K., Kakizawa, Y., Nishiyama, N., Harada, A., Yamasaki, Y., Koyama, H., & Kataoka, K. (2004). Block catiomer polyplexes with regulated densities of charge and disulfide cross-linking directed to enhance gene expression. J. Am. Chem. Soc., 126, 2355–61.
Mnyusiwalla, A., S., D. A., & Singer, P. A. (2003). 'Mind the gap': science and ethics in nanotechnology. Nanotechnology, 14, R9–R13.
National Science Foundation, USA. (February 2000). “Nanotechnology definition.” from http://www.nsf.gov/crssprgm/nano/reports/omb_nifty50.jsp.
Nel, A., Xia, T., Madler, L., & Li, N. (2006). Toxic potential of materials at the nanolevel. Science, 311, 622–7.
Niidome, T., Yamagata, M., Okamoto, Y., Akiyama, Y., Takahashi, H., Kawano, T., Katayama, Y., & Niidome, Y. (2006). PEG-modified gold nanorods with a stealth character for in vivo applications. J. Control. Release, 114, 343–7.
Oberdorster, G., Oberdorster, E., & Oberdorster, J. (2005). Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ. Health Perspect., 113, 823–39.
Orive, G., Hernandez, R. M., Rodriguez Gascon, A., Dominguez-Gil, A., & Pedraz, J. L. (2003). Drug delivery in biotechnology: present and future. Curr. Opin. Biotechnol., 14, 659–64.
Psaltis, D., Quake, S. R., & Yang, C. (2006). Developing optofluidic technology through the fusion of microfluidics and optics. Nature, 442, 381–6.
Ratner, B. D., Hoffman, A., Schoen, F., & Lemons, J. (2004). Biomaterials Science: An Introduction to Materials in Medicine. New York, Academic Press.
Reddy, G. R., Bhojani, M. S., Mcconville, P., Moody, J., Moffat, B. A., Hall, D. E., Kim, G., Koo, Y. E., Woolliscroft, M. J., Sugai, J. V., Johnson, T. D., Philbert, M. A., Kopelman, R., Rehemtulla, A., & Ross, B. D. (2006). Vascular targeted nanoparticles for imaging and treatment of brain tumors. Clin. Cancer. Res., 12, 6677–86.
Richards Grayson, A. C., Scheidt Shawgo, R., Li, Y., & Cima, M. J. (2004). Electronic MEMS for triggered delivery. Adv. Drug Deliv. Rev., 56, 173–84.
Ringsdorf, H. (1975). Structure and properties of pharmacologically active polymers. J. Polym. Sci. Polym. Sympo., 51, 135–153.
Roco, M. C. (2003). Nanotechnology: convergence with modern biology and medicine. Curr. Opin. Biotechnol., 14, 337–46.
Ryman-Rasmussen, J. P., Riviere, J. E., & Monteiro-Riviere, N. A. (2006). Penetration of intact skin by quantum dots with diverse physicochemical properties. Toxicol. Sci., 91, 159–65.
Salamanca-Buentello, F., Persad, D. L., Court, E. B., Martin, D. K., Daar, A. S., & Singer, P. A. (2005). Nanotechnology and the developing world. PLoS Med., 2, e97.
Sandler, R., & Kay, W. D. (2006). The national nanotechnology initiative and the social good. J. Law Med. Ethics, 34, 675–81.
Sawant, R. M., Hurley, J. P., Salmaso, S., Kale, A., Tolcheva, E., Levchenko, T. S., & Torchilin, V. P. (2006). “SMART” drug delivery systems: double-targeted pH-responsive pharmaceutical nanocarriers. Bioconjug. Chem., 17, 943–9.
Service, R. F. (2004). Nanotoxicology. Nanotechnology grows up. Science, 304, 1732–4.
Shimoboji, T., Larenas, E., Fowler, T., Hoffman, A. S., & Stayton, P. S. (2003). Temperature-induced switching of enzyme activity with smart polymer-enzyme conjugates. Bioconjug. Chem., 14, 517–25.
Shimoboji, T., Larenas, E., Fowler, T., Kulkarni, S., Hoffman, A. S., & Stayton, P. S. (2002). Photoresponsive polymer-enzyme switches. Proc. Natl. Acad. Sci. U S A, 99, 16592–6.
Shuai, X., Merdan, T., Schaper, A. K., Xi, F., & Kissel, T. (2004). Core-cross-linked polymeric micelles as paclitaxel carriers. Bioconjug. Chem., 15, 441–8.
The National Nanotechnology Initiative, USA. (July 2006). “Supplement to the President's 2007 budget.”
Tao, S. L., & Desai, T. A. (2005). Micromachined devices: the impact of controlled geometry from cell-targeting to bioavailability. J. Control. Release, 109, 127–38.
Thierry, B., Winnik, F. M., Merhi, Y., Silver, J., & Tabrizian, M. (2003). Bioactive coatings of endovascular stents based on polyelectrolyte multilayers. Biomacromolecules, 4, 1564–71.
Torchilin, V. P. (2006). Multifunctional nanocarriers. Adv. Drug Deliv. Rev., 58, 1532–55.
Whitesides, G. M. (2006). The origins and the future of microfluidics. Nature, 442, 368–73.
Yager, P., Edwards, T., Fu, E., Helton, K., Nelson, K., Tam, M. R., & Weigl, B. H. (2006). Microfluidic diagnostic technologies for global public health. Nature, 442, 412–8.
Ye, S., Wang, C., Liu, X., & Tong, Z. (2005). Deposition temperature effect on release rate of indomethacin microcrystals from microcapsules of layer-by-layer assembled chitosan and alginate multilayer films. J. Control. Release, 106, 319–28.
Yeo, Y., & Park, K. (2004). A new microencapsulation method using an ultrasonic atomizer based on interfacial solvent exchange. J. Control. Release, 100, 379–88.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 American Association of Pharmaceutical Scientists
About this chapter
Cite this chapter
Kim, S., Kwon, K., Kwon, I.C., Park, K. (2009). Nanotechnology in Drug Delivery: Past, Present, and Future. In: de Villiers, M.M., Aramwit, P., Kwon, G.S. (eds) Nanotechnology in Drug Delivery. Biotechnology: Pharmaceutical Aspects, vol X. Springer, New York, NY. https://doi.org/10.1007/978-0-387-77668-2_19
Download citation
DOI: https://doi.org/10.1007/978-0-387-77668-2_19
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-77667-5
Online ISBN: 978-0-387-77668-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)